Table 3.

Base case results representing an annual cohort from England (secondary outcomes)

Strategy	1(2)	2	3	4	5	6	7	8
Number of colonoscopies vs Strategy 1(1) (=4162)	+1618	+3044	+3008	+3401	+3381	+3381	+3842	+4400
Life expectancy of index patient vs Strategy 1(1) (=13.82 years)	+0.06	+0.10	+0.10	+0.12	+0.12	+0.12	+0.13	+0.14
Life expectancy of index patient with LS vs Strategy 1(1) (=12.93 years)	+0.72	+1.24	+1.24	+1.39	+1.39	+1.39	+1.56	+1.61
Life expectancy of relative vs Strategy 1(1) (=37.38 years)	+0.01	+0.05	+0.05	+0.05	+0.05	+0.05	+0.06	+0.06
Life expectancy of relative with LS vs Strategy 1(1) (=33.97 years)	+0.31	+1.24	+1.24	+1.39	+1.39	+1.39	+1.56	+1.61
Expected number of CRCs vs Strategy 1(1) (=664.9)	−8.36	−24.59	−24.56	−27.59	−27.57	−27.57	−30.95	−32.30
Expected number of ECs vs Strategy 1(1) (=53.8)	−4.99	−14.29	−14.29	−16.03	−16.03	−16.03	−17.97	−18.55

Abbreviations: EC endometrial cancer.